MIRA INFORM REPORT

 

 

Report Date :

22.08.2014 

 

IDENTIFICATION DETAILS

 

Name :

SALVAMED AD

 

 

Registered Office :

Promishlena Zona 2800 Sandanski

 

 

Country :

Bulgaria

 

 

Financials (as on) :

2013

 

 

Date of Incorporation :

19.05.1998

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacture of made-up textile articles, except apparel

 

 

No. of Employees

239

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

Slow but correct

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Bulgaria

C2

C2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

BULGARIA ECONOMIC OVERVIEW

 

Bulgaria, a former Communist country that entered the EU on 1 January 2007, averaged more than 6% annual growth from 2004 to 2008, driven by significant amounts of bank lending, consumption, and foreign direct investment. Successive governments have demonstrated a commitment to economic reforms and responsible fiscal planning, but the global downturn sharply reduced domestic demand, exports, capital inflows, and industrial production. GDP contracted by 5.5% in 2009, and has been slow to recover in the years since. Despite having a favorable investment regime, including low, flat corporate income taxes, significant challenges remain. Corruption in public administration, a weak judiciary, and the presence of organized crime continue to hamper the country's investment climate and economic prospects

 

Source : CIA

 

 

 


Company name and address

 

SALVAMED AD


International Name: SALVAMED JSC

Principal Address:
Promishlena zona mestnost "Sokolovets"
2800 SANDANSKI
Bulgaria
Telephone: +359-746-31070, +359-746-1555105, +359-746-1555110
Fax: +359-746-38798
Email: info@salvamed.bg
Web: http://salvamed.bg

Registered office:
PROMISHLENA ZONA
2800 Sandanski
Bulgaria
Telephone: +359-746-31554, +359-746-38798, +359-888-727296
Fax: +359-746-38798
Email: pankovski@salvamed.bg, k.kostadinova@salvamed.bg
Web: www.salvamed.bg

 

Former company addresses
Former Registered office:
ul. PETAR BERON № 2
2800 SANDANSKI
Bulgaria
Telephone: +359-746-31554, +359-746-31555
Fax: +359-746-38798

 

 

 

 

ICON number: 15447880
National ID: 101109943
VAT number: BG101109943

 

 

Registration status: 19.05.1998 - registered company
Activity status: active company

 

 

Date of Last Research:

21.08.2014

 


 

DIRECTORS/MANAGEMENT

 

Management:

Full Name

Function

Address

DJORDJO DJOVONORDI
Nationality: BG
09.07.2010 - since

Board of directors

 

TANYA TSVETKOVA ILIEVA-STOYANOVA
09.07.2010 - since

Board of directors

Bulgaria

MASIMO KROCHI
Nationality: BG
09.07.2010 - since

Board of directors

 

LUIDJI SALVADORI
09.07.2010 - since

Board of directors

Italy

DANIEL RADULESKO
Nationality: BG
09.07.2010 - since

Board of directors

 

 

 

NEGATIVE INFORMATION

 

No negative information found.

 

 

 

SHARE & SHARE CAPITAL INFORMATION

 

Capital:

Nominal capital:

 

EUR 1.610.182,49

 

Number of Ordinary shares:

3.150.000

 

Value per share of Ordinary shares:

EUR 0,51

 

 

Shareholders:

Full Name

Function

Address

Equity capital

LUIGGI SALVATORI SA
Registration: Italy

Shareholder

 

95,00%

LUIDJI SALVADORI

Shareholder

Italy

2,50%

MASIMO KROCHI
Nationality: BG

Shareholder

 

1,25%

SERDJO KROCHI
Nationality: IT

Shareholder

 

1,25%

 

PAYMENT INFORMATION

 

Payment Practices:

No adverse payment incidents known at this time

 

 

 

 

Debt Collection

There is no record of any debt collection action by Coface Bulgaria Credit Management Services EOOD against this company.

 

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

Related Companies:

shareholder is
LUIGGI SALVATORI SA , Italy
shareholder of
FINANTSA END PRODJETTI BULKONSULTING , Bulgaria , National ID: 175401289
FINANTSA END PRODJETTI BULKONSULTING OOD, EIK: 175401289

 

 

FINANCIAL INFORMATION

 

Further Rating Information:

Researched company is categorized as a big company.
Turnover volume of EUR 8.318.254 in the year 2013 increased by 3,96% compared with 2012. In the previous period this change was -1,59%.
Fixed assets decreased by EUR 144.530 and now 52,32% of total assets.
Working capital of EUR 2.020.651 increased for 479,23% compared with the last period.
Cash flow from results of EUR 793.846 decreased by 0,13% compared with last year result.

 

 

Financials

Amounts shown in Euro (EUR) 

2013

2012

2011

2010

 


BALANCE SHEET

 

ASSETS

12.580.381,33

13.500.767,26

11.603.580,56

8.489.002,56

 

Fixed assets

6.582.323,77

6.726.854,22

5.458.312,02

3.273.657,29

 

Intangible assets

170.730,46

142.199,49

174.936,06

207.161,13

 

Tangible assets

6.411.082,14

6.584.143,22

5.282.864,45

3.065.984,65

 

Financial assets

511,17

511,51

511,51

511,51

 

CURRENT ASSETS

5.998.057,56

6.773.913,04

6.145.268,54

5.215.345,27

 

Stock

2.994.428,26

3.259.335,04

3.266.496,16

2.924.296,68

 

Receivables

2.831.876,50

3.480.818,41

2.851.150,90

2.276.726,34

 

Other assets

71.052,50

26.598,47

17.902,81

8.184,14

 

LIABILITIES

12.580.381,33

13.500.767,26

11.603.580,56

8.489.002,56

 

Shareholders funds

2.072.790,47

2.137.595,91

2.191.304,35

2.233.759,59

 

Share capital

1.610.182,49

1.611.253,20

1.611.253,20

1.611.253,20

 

Reserves

171.752,80

171.867,01

171.867,01

171.867,01

 

Total long term debts

6.530.184,53

4.938.107,42

2.991.815,86

2.761.125,32

 

Total short term debts

3.977.406,33

6.425.063,94

6.420.460,36

3.494.117,65

 

PROFIT AND LOSS ACCOUNT

 

 

Turnover

8.318.253,85

8.001.534,53

8.130.946,29

7.887.468,03

 

Production

7.480.447,78

7.135.038,36

7.349.360,61

7.180.562,66

 

General costs

7.480.447,78

7.135.038,36

7.349.360,61

7.180.562,66

 

Operating profit

837.806,06

866.496,16

781.585,68

706.905,37

 

Financial result / Financial costs

-515.258,40

-458.823,53

-379.028,13

-258.312,02

 

Extraordinary result / profit

0,00

0,00

0,00

0,00

 

Pretax profit / loss

322.547,67

331.969,31

402.557,54

448.593,35

 

Taxes

31.692,48

13.299,23

36.828,64

39.897,70

 

Profit / loss after tax

290.855,19

394.373,40

365.728,90

408.695,65

 

 

Ratios

 

 

 

 

 

Industry average

 

 

2013

2012

2011

2010

 

2013

2012

2011

2010

 

 

LIQUIDITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current ratio
Current Assets / Current Liabilities

1,51

1,05

0,96

1,49

 

 

 

 

1,57

 

 

 

 

 

Quick ratio
(Current assets - Inventory)/Current liabilities

0,76

0,55

0,45

0,66

 

 

 

 

0,72

 

 

 

 

 

Cash ratio
Cash / Current liabilities

0,02

0,00

0,00

0,00

 

 

 

 

0,22

 

 

 

 

 

Net working capital
(Current assets - Short-term liabilities)/1000 (in Thousands)

EUR 2.020,65

EUR 348,85

EUR -275,19

EUR 1.721,23

 

 

 

 

 

 

 

 

 

 

 

PROFITABILITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit margin
(Sales - Material costs) / Sales * 100

28,07

29,64

26,71

26,78

 

 

 

 

 

 

 

 

 

 

EBITDA Margin (%)
(EBITDA / Turnover) * 100

16,12

15,83

14,28

14,94

 

 

 

 

 

 

 

 

 

 

EBIT Margin (%)
(EBIT / Turnover) * 100

10,07

10,83

9,61

8,96

 

 

 

 

 

 

 

 

 

 

Net Profit Margin (%)
(Net Profit / Turnover) * 100

3,50

4,93

4,50

5,18

 

 

 

 

 

 

 

 

 

 

ROE (%)
(Net Profit / Total Equity) * 100

14,03

18,45

16,69

18,30

 

 

 

 

13,33

 

 

 

 

 

ROA (%)
(Net Profit / Total Assets) * 100

2,31

2,92

3,15

4,81

 

 

 

 

6,93

 

 

 

 

 

ROFA (%)
(Net Profit / Fixed Assets) * 100

4,42

5,86

6,70

12,48

 

 

 

 

 

 

 

 

 

 

 

INDEBTNESS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity ratio
Equity Capital / Total Assets

0,16

0,16

0,19

0,26

 

 

 

 

 

 

 

 

 

 

Total Liabilities/Total Assets
Total Liabilities / Total Assets

0,84

0,84

0,81

0,74

 

 

 

 

0,55

 

 

 

 

 

Debt/Equity

5,07

5,32

4,30

2,80

 

 

 

 

2,20

 

 

 

 

 

Gearing ratio 2 (Bank Loans to Capital)
Total Bank Debt / Total Equity

4,47

4,60

3,20

1,52

 

 

 

 

 

 

 

 

 

 

Leverage
Long Term Liabilities / Total Equity

3,15

2,31

1,37

1,24

 

 

 

 

 

 

 

 

 

 

Interest coverage ratio
EBIT / Financial Expenses

1,63

1,89

2,00

2,69

 

 

 

 

 

 

 

 

 

 

EBITDA-to-Interest Coverage Ratio
EBITDA / Financial Expenses

2,60

2,76

2,98

4,48

 

 

 

 

 

 

 

 

 

 

 

ACTIVITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collection Period (in days)
(Accounts Receivable / Turnover) * 365

124,26

158,78

127,99

105,36

 

 

 

 

 

 

 

 

 

 

Payables turnover (in days)
(Accounts Payable / COGS) * 365

46,68

64,53

70,27

48,07

 

 

 

 

 

 

 

 

 

 

Inventory rotation (in days)
(Inventory / COGS) * 365

182,67

211,30

200,08

184,81

 

 

 

 

 

 

 

 

 

 

Cash conversion cycle
DIO + DSO - DPO

260,25

305,55

257,79

242,10

 

 

 

 

 

 

 

 

 

 

Asset turnover
Turnover / Total Assets

0,66

0,59

0,70

0,93

 

 

 

 

 

 

 

 

 

 

Fixed Assets Turnover Ratio
Turnover / Fixed Assets

1,26

1,19

1,49

2,41

 

 

 

 

 

 

 

 

 

 

 


Industry average values are listed for the NACE branch: C – Manufacturing

 

Currency Conversion Information:

Financial values have been converted to EUR.
Find below the exchange rates used for the listed financial dates:
2010: 1 EUR = 1,96 BGN (yearly average rate 2010)
2011: 1 EUR = 1,96 BGN (yearly average rate 2011)
2012: 1 EUR = 1,96 BGN (yearly average rate 2012)

 

 

FOREIGN EXCHANGE RATES

 

Approximate Exchange Rates:

2012: 1,9569 BGN = 1 EUR
2011: 1,9569 BGN = 1 EUR
2010: 1,9569 BGN = 1 EUR
2009: 1,9569 BGN = 1 EUR
2008: 1,9569 BGN = 1 EUR
2007: 1,9569 BGN = 1 EUR
2012: 1,5223 BGN = 1 USD
2011: 1,4051 BGN = 1 USD
2010: 1,4753 BGN = 1 USD
2009: 1,4022 BGN = 1 USD
2008: 1,3298 BGN = 1 USD
2007: 1,4271 BGN = 1 USD

 

 

ADDITIONAL INFORMATION

 

Insolvency Information:

According to available information sources the company is not in a insolvency/preliminary/debt regulation proceeding.

 

Established:

1998

 

 

Registration:

No. 871
19.05.1998
District court Blagoevgrad, Bulgaria

 

 

Legal Form:

joint stock company

 

 

History:

SALVAMED, born as a branch of Luigi Salvadori Spa (medical dressing current leader of italian market), has been certificated by Istituto Superiore Della Sanita with CE MARK 0373.
Pure cotton gauze and nowoven Lap Sponges and swabs are produced in the 2.000 sq. mts "Clean Room" located in Sandanski - Bulgaria with a staff that includes over 200 people.
SALVAMED owns the machinery for the production and the processing of cotton gauze, among which let us mention fully automatic machines for the production of Lap Sponges.

 

Person functions in other companies:

Function

Company

Other known functions of  LUIDJI SALVADORI

Partner

MARGARITA-FASON (BG)
National ID: 101650436

Managing director

EY END EY OLIVAR (BG)
National ID: 124651173

Partner

EY END EY OLIVAR (BG)
National ID: 124651173

Board of directors

"TINKEY" - v likvidatsiya (BG)
National ID: 175979193

Partner

BORUNA INVESTMANT (BG)
National ID: 200085860

Board of directors

VELLUM EDJUKEYSHANAL SARVISIS BALGARIYA (BG)
National ID: 200499548

Managing director

Klasik Holidey Park (BG)
National ID: 200910775

Partner

Klasik Holidey Park (BG)
National ID: 200910775

Proprietor

KLANOTEKS (BG)
National ID: 201198964

Managing director

KLANOTEKS (BG)
National ID: 201198964

Proprietor

NATALI I SINOVE (BG)
National ID: 202163934

Managing director

NATALI I SINOVE (BG)
National ID: 202163934

Other known functions of  DJOVONORDI DJORDJO

Managing director

CHEH-BOLGAR-INVEST (BG)
National ID: 120005080

Partner

BRATYA HADJIVARITIS (BG)
National ID: 131408150

Managing director

VILAS 4 YU 2 RENT (BG)
National ID: 147165117

Partner

VILAS 4 YU 2 RENT (BG)
National ID: 147165117

Proprietor

KOMOSHAN (BG)
National ID: 124679404

Managing director

KOMOSHAN (BG)
National ID: 124679404

Managing director

KINLISAYD (BG)
National ID: 127588454

Partner

KINLISAYD (BG)
National ID: 127588454

Managing director

Hadji Farma (BG)
National ID: 200090101

Partner

Hadji Farma (BG)
National ID: 200090101

Managing director

CHARLZ END PRIYS (BG)
National ID: 200739071

Partner

CHARLZ END PRIYS (BG)
National ID: 200739071

Other known functions of  RADULESKO DANIEL

Partner

KOMPAS (BG)
National ID: 101687121

Partner

BORUNA INVESTMANT (BG)
National ID: 200085860

Managing director

LIS - LAHVAENKO (BG)
National ID: 200640397

Partner

LIS - LAHVAENKO (BG)
National ID: 200640397

Proprietor

HIPSARION (BG)
National ID: 200930023

Managing director

HIPSARION (BG)
National ID: 200930023

 

Subject of Operation:

NACE
  1392 Manufacture of made-up textile articles, except apparel

Production of medical and hygienic dressings.(ladies' towels etc)
NACE codes given are based on the most recent NACE Revision 2.

The company is active in the Coface sector 'Textiles, leather and clothing'.

 

Workforce:

 

31.05.2014

2013

2012

2011

Total workforce

239

213

209

208

 

Contact With Company:

Marketing
+35974631555105
+35974631070
i.panev@salvamed.bg

+35974631555110
k.kostadinova@salvamed.bg

 

 

VAT registration details:

05.10.1998

 

 

NOTES & COMMENTS

 

N/a

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.76

UK Pound

1

Rs.100.72

Euro

1

Rs.80.55

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

NIS

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

 

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.